US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Aspirin DR Enteric Coated Tablets

Reason Failed Dissolution Specification; at the 12 month time interval.

Mckesson Packaging Services D-1483-2014
Class III · Low risk Terminated

Velivet

Reason Failed Impurities/Degradation Specifications: out of specification impurity test results.

Teva Pharmaceuticals USA NDC 0555-9051-67 D-1439-2014
Class III · Low risk Terminated

Kariva

Reason Failed Impurities/Degradation Specifications: out of specification impurity test results.

Teva Pharmaceuticals USA NDC 0555-9050-58 D-1438-2014
Class III · Low risk Terminated

Mircette

Reason Failed Impurities/Degradation Specifications: out of specification impurity test results.

Teva Pharmaceuticals USA NDC 51285-114-58 D-1437-2014
Class III · Low risk Terminated

Apri

Reason Failed Impurities/Degradation Specifications: out of specification impurity test results.

Teva Pharmaceuticals USA NDC 0555-9043-58 D-1436-2014
Class III · Low risk Terminated

Aplenzin¿

Reason Labeling: Incorrect or Missing Package Insert

Valeant Pharmaceuticals North America LLC NDC 0024-5812-07 D-0053-2015
Class III · Low risk Terminated

Aplenzin¿

Reason Labeling: Incorrect or Missing Package Insert

Valeant Pharmaceuticals North America LLC NDC 0024-5811-07 D-0052-2015
Class III · Low risk Terminated

Aplenzin¿

Reason Labeling: Incorrect or Missing Package Insert

Valeant Pharmaceuticals North America LLC NDC 0024-5810-07 D-0051-2015
Class III · Low risk Terminated

Foradil Aerolizer

Reason Failed Stability Specification; out of specification result for particle size distribution during stability testing

Novartis Pharmaceuticals Corp. NDC 0085-1401-01 D-1387-2014
Class III · Low risk Terminated

Vasotec

Reason Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.

Valeant Pharmaceuticals North America LLC NDC 0187-0140-90 D-0019-2015
Class III · Low risk Terminated

Vaseretic

Reason Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset

Valeant Pharmaceuticals North America LLC NDC 0187-0146-01 D-0018-2015
Class III · Low risk Terminated

Oasis TEARS

Reason Labeling: Missing Label; The label on the immediate bottle is missing.

Oasis Medical Inc D-1347-2014
Class III · Low risk Terminated

PediaCare brand NIGHTTIME MULTI-SYMPTOM Cold

Reason Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution

Prestige Brands Holdings D-1352-2014
Class III · Low risk Terminated

Olanzapine Orally Disintegrating Tablets 5 mg

Reason Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.

Apotex Corp. NDC 60505-3275-03 D-1609-2014
Class III · Low risk Terminated

Triveen - PRx RNF Capsules

Reason Labeling: Not Elsewhere Classified: Label indicates that the product contains Vitamin B12 (12 micrograms) on the Supplement Facts panel, however, the formulation of this product does not contain Vitamin B12.

Trigen Laboratories, Inc. NDC 13811-558-30 D-1544-2014
Class III · Low risk Terminated

Wockhardt Metoprolol Succinate

Reason Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.

Wockhardt Usa Inc. NDC 64679-735-02 D-0304-2015
Class III · Low risk Terminated

Oxandrolone Tablets

Reason Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.

Upsher Smith Laboratories, Inc. NDC 0245-0272-06 D-1255-2014
Class III · Low risk Terminated

Day Time Cold & Flu

Reason Subpotent Drug: Phenylephrine component is subpotent.

P&L Developments, LLC D-1254-2014
Class III · Low risk Terminated

Haloperidol Decanoate Injection

Reason Failed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.

Fresenius Kabi USA LLC NDC 63323-469-01 D-0247-2015
Class III · Low risk Terminated

Children's Cetirizine Hydrochloride Chewable Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide

Caraco Pharmaceutical Laboratories, Ltd. NDC 47335-344-83 D-1297-2014
Class III · Low risk Terminated

Cetirizine Hydrochloride Chewable Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide

Caraco Pharmaceutical Laboratories, Ltd. NDC 47335-343-83 D-1296-2014